Sam Jackson

648 total citations
20 papers, 343 citations indexed

About

Sam Jackson is a scholar working on Neurology, Immunology and Physiology. According to data from OpenAlex, Sam Jackson has authored 20 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 5 papers in Immunology and 4 papers in Physiology. Recurrent topics in Sam Jackson's work include Multiple Sclerosis Research Studies (3 papers), Amyotrophic Lateral Sclerosis Research (3 papers) and Immunotherapy and Immune Responses (3 papers). Sam Jackson is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Amyotrophic Lateral Sclerosis Research (3 papers) and Immunotherapy and Immune Responses (3 papers). Sam Jackson collaborates with scholars based in United Kingdom, United States and New Zealand. Sam Jackson's co-authors include Gavin Giovannoni, Konrad Rejdak, Robert S. Janssen, Randall N. Hyer, William L. Heyward, Darren K. McGuire, Biao Xing, Steven P. Braithwaite, Karoly Nikolich and Maria Coburn and has published in prestigious journals such as Neurology, American Journal of Respiratory and Critical Care Medicine and Journal of Neurochemistry.

In The Last Decade

Sam Jackson

19 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sam Jackson United Kingdom 9 95 83 68 67 62 20 343
Tian Wang China 12 108 1.1× 20 0.2× 83 1.2× 31 0.5× 62 1.0× 43 388
Thomas United Kingdom 11 63 0.7× 33 0.4× 52 0.8× 25 0.4× 23 0.4× 21 320
Nailú Angélica Sinicato Brazil 11 169 1.8× 27 0.3× 43 0.6× 36 0.5× 28 0.5× 22 392
Maria Lymperi Greece 11 81 0.9× 40 0.5× 83 1.2× 12 0.2× 35 0.6× 26 351
Joseph A. Lopez United States 8 94 1.0× 18 0.2× 80 1.2× 82 1.2× 40 0.6× 14 341
Wen-Yi Tseng Taiwan 14 129 1.4× 25 0.3× 175 2.6× 34 0.5× 47 0.8× 24 479
Patricia Vega Argentina 11 57 0.6× 32 0.4× 83 1.2× 29 0.4× 30 0.5× 18 413
Ana Míriam Saldaña-Cruz Mexico 10 70 0.7× 48 0.6× 74 1.1× 31 0.5× 44 0.7× 51 293
Si Wu China 9 46 0.5× 42 0.5× 126 1.9× 12 0.2× 43 0.7× 19 344
Xuerui Tan China 8 47 0.5× 28 0.3× 74 1.1× 14 0.2× 43 0.7× 17 333

Countries citing papers authored by Sam Jackson

Since Specialization
Citations

This map shows the geographic impact of Sam Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Jackson more than expected).

Fields of papers citing papers by Sam Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Jackson. The network helps show where Sam Jackson may publish in the future.

Co-authorship network of co-authors of Sam Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Jackson. A scholar is included among the top collaborators of Sam Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Jackson. Sam Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huang, Julie Y., Robert Paul, Felix L. Yeh, et al.. (2022). A Phase 2 Study of AL001 in Frontotemporal Dementia Patients Carrying a Granulin Mutation (P5-3.005). Neurology. 98(18_supplement). 2 indexed citations
3.
4.
Ward, Michael E., Robert Paul, Hua Long, et al.. (2022). A Phase 1 Study of AL002 in Healthy Volunteers (P5-3.004). Neurology. 98(18_supplement). 3 indexed citations
5.
Jackson, Sam, Felix L. Yeh, Michael E. Ward, et al.. (2021). Six months interim analysis of the phase 2 study of AL001 in frontotemporal dementia patients carrying a granulin mutation. Alzheimer s & Dementia. 17(S9). 1 indexed citations
6.
7.
Psallidas, Ioannis, Vibeke Backer, Piotr Kuna, et al.. (2020). A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma. American Journal of Respiratory and Critical Care Medicine. 203(3). 296–306. 17 indexed citations
8.
Jackson, Sam, et al.. (2020). Soldiering on only goes so far: How a qualitative study on Veteran loneliness in New Zealand influenced that support during COVID-19 lockdown. Journal of Military Veteran and Family Health. 6(S2). 60–69. 4 indexed citations
9.
Jackson, Sam, et al.. (2020). Soldiering on only goes so far: How a qualitative study on Veteran loneliness in New Zealand influenced that support during COVID-19 lockdown. Journal of Military Veteran and Family Health. 6(S2). 60–69. 2 indexed citations
10.
Hannestad, Jonas, Rebecca D. Ray, Antonio Páez, et al.. (2020). Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia. Alzheimer s & Dementia Translational Research & Clinical Interventions. 6(1). e12115–e12115. 13 indexed citations
11.
Jackson, Sam, et al.. (2019). Results of a survey on the use of the functional observational battery (FOB) and Irwin tests in central nervous system (CNS) safety pharmacology. Journal of Pharmacological and Toxicological Methods. 99. 106595–106595. 1 indexed citations
12.
Hyer, Randall N., Darren K. McGuire, Biao Xing, Sam Jackson, & Robert S. Janssen. (2018). Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults. Vaccine. 36(19). 2604–2611. 42 indexed citations
13.
Prior, Helen, et al.. (2018). Why are non-rodents not socially housed during cardiovascular telemetry recordings on safety pharmacology studies?. Journal of Pharmacological and Toxicological Methods. 93. 158–158. 1 indexed citations
14.
Sha, Sharon J., Gayle K. Deutsch, Lü Tian, et al.. (2018). Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study. JAMA Neurology. 76(1). 35–35. 92 indexed citations
15.
Jackson, Sam, Albert F. Candia, Stephen Delaney, et al.. (2017). First‐in‐Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well‐Tolerated. Clinical Pharmacology & Therapeutics. 104(2). 335–345. 22 indexed citations
16.
17.
18.
Gnanapavan, Sharmilee, Peggy P. Ho, Wendy Heywood, et al.. (2013). Progression in multiple sclerosis is associated with low endogenous NCAM. Journal of Neurochemistry. 125(5). 766–773. 15 indexed citations
19.
Gnanapavan, Sharmilee, Donna Grant, Gareth Pryce, et al.. (2012). Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis. Autoimmunity. 45(4). 298–303. 11 indexed citations
20.
Rejdak, Konrad, Sam Jackson, & Gavin Giovannoni. (2010). Multiple sclerosis: a practical overview for clinicians. British Medical Bulletin. 95(1). 79–104. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tian Wang Breakdown of academic impact, for papers by Thomas Breakdown of academic impact, for papers by Nailú Angélica Sinicato Breakdown of academic impact, for papers by Maria Lymperi Breakdown of academic impact, for papers by Joseph A. Lopez Breakdown of academic impact, for papers by Wen-Yi Tseng Breakdown of academic impact, for papers by Patricia Vega Breakdown of academic impact, for papers by Ana Míriam Saldaña-Cruz Breakdown of academic impact, for papers by Si Wu Breakdown of academic impact, for papers by Xuerui Tan
Rankless by CCL
2026